Is the FDA’s decision to delay Sarepta drug decision good or bad? Nobody really knows

Eteplirsen, if approved, would be the only treatment for the rare disease Duchenne muscular dystrophy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.